Autosomal Dominant Optic Atrophy: Clinical Trials

4 trials for Autosomal Dominant Optic Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Recruiting 1
Phase 21Recruiting 1

Follow Autosomal Dominant Optic Atrophy: new trials by email Literature Review of Autosomal Dominant Optic Atrophy trials Research Report on Autosomal Dominant Optic Atrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle)
PYC-001 - OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy
Phase 1 / Phase 2RecruitingPYC Therapeutics242025-09-302026-06-29
SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)
PYC-001 - OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy
Phase 1Active not recruitingPYC Therapeutics182024-10-312026-09-17
Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation
Autosomal Dominant Optic Atrophy, Optic Atrophy, Autosomal Dominant
TerminatedPYC Therapeutics12024-02-282025-03-14
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingSanford Health200002010-07-012026-10-28

Narrower conditions

Optic Atrophy, Autosomal Dominant (4)  ·  Optic Atrophies, Hereditary (3)  ·  3-Methylglutaconic Aciduria, Type V (1)  ·  Achalasia Addisonianism Alacrimia syndrome (1)  ·  Acrodysostosis (1)  ·  Activated PI3K-delta Syndrome (1)  ·  Addison Disease (1)  ·  Alagille Syndrome (1)  ·  Alstrom Syndrome (1)  ·  Amnesia, Transient Global (1)  ·  Aniridia (1)  ·  Aniridia and Absent Patella (1)  ·  Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1)  ·  Ataxia (1)  ·  Ataxia Neuropathy Spectrum (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Cranial Nerve Diseases (4)  ·  Eye Diseases (4)  ·  Eye Diseases, Hereditary (4)  ·  Genetic Diseases, Inborn (4)  ·  Heredodegenerative Disorders, Nervous System (4)  ·  Metabolic Diseases (4)  ·  Nervous System Diseases (4)  ·  Neurodegenerative Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Optic Atrophy (4)  ·  Optic Nerve Diseases (4)  ·  Mitochondrial Diseases (3)  ·  Abnormalities, Multiple (1)  ·  Adrenal Gland Diseases (1)

Sponsors

PYC Therapeutics (3)  ·  Sanford Health (1)

Countries

Australia (3)  ·  United States (2)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  New Zealand (1)

Top investigators

Aishwarya Kundu (1)  ·  Sreenivasu Mudumba, PhD (1)